Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025
17 juil. 2023 11h45 HE
|
Mithra Pharmaceuticals
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025 (ISIN: BE6325746855) Liege, Belgium, 17 July 2023 – 17:45 CEST – Mithra...
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025 (ISIN: BE6325746855)
04 juil. 2023 11h45 HE
|
Mithra Pharmaceuticals
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025 (ISIN: BE6325746855) Liege, Belgium, 4 July 2023 – [17:45 CEST] – Mithra...
Mithra Announces Information on the Total Number of Voting Rights (Denominator)
26 juin 2023 11h45 HE
|
Mithra Pharmaceuticals
Mithra Announces Information on the Total Number of Voting Rights (Denominator) Liege, Belgium, 26 June 2023 – 17:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s...
Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility
21 juin 2023 14h38 HE
|
Mithra Pharmaceuticals
Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility Liege, Belgium, 21 June 2023 – 17:50 CEST – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the...
Mithra Announces New Positive Preclinical Data from CSF-1R Inhibitor Program
15 juin 2023 01h30 HE
|
Mithra Pharmaceuticals
Mithra Announces New Positive Preclinical Data from CSF-1R Inhibitor Program CSF-1R inhibitors show promising anti-tumor activityLead compound shows synergy with PD1 cancer immune checkpoint...
Mithra - Publication of a transparency notification received from Scorpiaux BV
05 juin 2023 11h45 HE
|
Mithra Pharmaceuticals
Publication of a transparency notification received from Scorpiaux BV Liege, Belgium, 05 June 2023 – 17:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today...
Mithra Appoints Experienced Life Sciences Executive Christian Homsy* as Chairman
29 mai 2023 01h30 HE
|
Mithra Pharmaceuticals
Inge Beernaert appointed President of the Compensation and Nomination CommitteeJacques Galloy appointed President of the Audit Committee Liege, Belgium, 29 May 2023 – 7:30 CEST – Mithra (Euronext...
Mithra’s General Meeting Of Shareholders Approves the Renewal of its Board of Directors
25 mai 2023 12h39 HE
|
Mithra Pharmaceuticals
Mithra’s General Meeting Of Shareholders Approves the Renewal of its Board of Directors Liege, Belgium, 25 MAY 2023 – 5:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to...
Mithra - Letter to Shareholders and Corporate Update
25 mai 2023 01h30 HE
|
Mithra Pharmaceuticals
Letter to Shareholders and Corporate Update Access to EUR15 million under amended dealDonesta® U.S. marketing deal is a key near term priorityCDMO strategic options are being exploredDonesta®...
Mithra - Letter to Shareholders and Corporate Update
25 mai 2023 01h30 HE
|
Mithra Pharmaceuticals
Letter to Shareholders and Corporate Update Access to EUR15 million under amended dealDonesta® U.S. marketing deal is a key near term priorityCDMO strategic options are being exploredDonesta®...